Melanoma-Independent Community Advisory Board (M-ICAB) 2nd Conference Summary
We are pleased to be sharing with you a full narrative summary from European Cancer Patient Coalition’s Melanoma-Independent Community Advisory Board (M-ICAB) 2nd conference that took place April 23-24 in Brussels. The narrative can be uploaded here http://www.m-icab.org/
Thank you again to those of you who were able to attend and make the conference a constructive and dynamic experience. Most of the slides from the conference will be soon available on the M-ICAB website.
As many of you know, ECPC engages with a range of policy work at the EU level. For the ECPC M-ICAB initiative, your insights and perspective have allowed us to define a plan for moving forward in our mission to ensure that the landscape of melanoma treatment and support is continually improving.
The narrative captures brief summaries of each session and presentation, and highlights key point that were filtered through the discussions. Importantly, it captures potential action items for our endeavors to construct a white paper that will focus on key strategic issues and regulations that will need to be impacted by all melanoma stakeholders.
Please do let us know if you have specific questions or comments regarding the summary. We value your perspective on the takeaways and opportunities identified at the conference. Please do email Francesca about this feedback: email@example.com
We will be in touch as we narrow down the focus of the White Paper to one that will be realistic and actionable. We welcome your thoughts and support in this endeavor.
All our very best,
Prof. Patricia Garcia Prieto
President and founder of M-ICAB
ECPC Head of External and Policy Affair
Viewing 1 post (of 1 total)
The forum ‘Melanoma Diagnosis: Stage IV’ is closed to new topics and replies.